Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Critical Care
•
Hospital Medicine
Do you utilize scheduled acetaminophen in patients with sepsis and respiratory or circulatory organ failure?
Do the findings from the ASTER trial (PMID: 38762798) influence your approach?
Related Questions
How do you decide whether to use pharmacologic VTE prophylaxis in hospitalized patients with decompensated cirrhosis?
What do you think about using conventional thoracic imaging methods (e.g., X-ray, CT, etc.) to determine if a pleural effusion is of adequate size to consider thoracentesis?
How do you identify which patients are at highest risk for decompensation and most likely to benefit from NIV for pre-oxygenation prior to intubation?
What is your approach to VTE prophylaxis in hospitalized patients who are already on DAPT?
Do you routinely discontinue atypical coverage in community-acquired pneumonia when PCR testing (i.e., respiratory pathogen panel) is negative for atypical organisms?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
How would you approach the management of a patient who develops an accelerated junctional rhythm who exhibits no symptoms and has no prior history of cardiac issues, aside from consulting a cardiologist?
Does the use of NIV for pre-oxygenation delay the time to intubation?
When do you recommend starting a continuous opioid infusion for symptom control at the end of life?
How do you decide which IV opioid to use for symptom relief at the end of life?